EDGAR Filing Documents for 0001193125-13-178388

Form DEF 14A - Other definitive proxy statements:

SEC Accession No. 0001193125-13-178388

Filing Date

2013-04-29

Accepted

2013-04-26 18:26:25

Documents

Period of Report

2013-06-14

Effectiveness Date

2013-04-29

Document Format Files

Seq	Description	Document	Type	Size
1	DEFINITIVE PROXY STATEMENT	d526240ddef14a.htm	DEF 14A	870463
2	GRAPHIC	g526240alfred_gilman.jpg	GRAPHIC	10056
3	GRAPHIC	g526240arthur_ryan.jpg	GRAPHIC	9783
4	GRAPHIC	g526240charles_baker.jpg	GRAPHIC	10077
5	GRAPHIC	g526240christine_poon.jpg	GRAPHIC	10155
6	GRAPHIC	g526240eric_shooter.jpg	GRAPHIC	10713
7	GRAPHIC	g526240g00l75.jpg	GRAPHIC	10199
8	GRAPHIC	g526240g53y21.jpg	GRAPHIC	7050
9	GRAPHIC	g526240g88r49.jpg	GRAPHIC	6797
10	GRAPHIC	g526240george_sing.jpg	GRAPHIC	10586
11	GRAPHIC	g526240george_yancopoulos.jpg	GRAPHIC	10270
12	GRAPHIC	g526240joseph_goldstein.jpg	GRAPHIC	9709
13	GRAPHIC	g526240leonard_schleifer.jpg	GRAPHIC	10187
14	GRAPHIC	g526240marc_tessier.jpg	GRAPHIC	10663
15	GRAPHIC	g526240micheal_brown.jpg	GRAPHIC	10235
16	GRAPHIC	g526240pc1.jpg	GRAPHIC	1667
17	GRAPHIC	g526240pc2.jpg	GRAPHIC	1781
18	GRAPHIC	g526240roy_vagelos.jpg	GRAPHIC	10546
	Complete submission text file	0001193125-13-178388.txt		1081422

Mailing Address

Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000

REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)